Assessment of risk factors associated with outpatient parenteral antimicrobial therapy complications

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy complications

Background: Outpatient parenteral antimicrobial therapy (OPAT) is used in the outpatient setting to treat infectious conditions that require a prolonged course of antimicrobials. OPAT has been shown to decrease length of hospital stay and healthcare costs without compromising patient care and has be...

Full description

Bibliographic Details
Main Authors:	Christina Kaul, Jenny Yang, Matthew Haller, Sadie Solomon, Yaojie Wang, Rong Wu, Yu Meng, Robert Pitts, Michael Phillips
Format:	Article
Language:	English
Published:	Cambridge University Press 2022-07-01
Series:	Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:	https://www.cambridge.org/core/product/identifier/S2732494X22000870/type/journal_article

Similar Items

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy (OPAT) complications: A retrospective cohort study
by: Christina M. Kaul, et al.
Published: (2022-01-01)

Outpatient parenteral antimicrobial therapy in Brazil
by: Priscila R Oliveira, et al.
Published: (2023-06-01)

Recommendations for outpatient parenteral antimicrobial therapy in Brazil
by: Priscila R. Oliveira, et al.
Published: (2017-11-01)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
by: Tanner M. Johnson, et al.
Published: (2023-08-01)

Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care
by: Dylan Rajaratnam, et al.
Published: (2023-02-01)

Survey of pharmacists on their roles and perceptions of outpatient parenteral antimicrobial therapy in the United States
by: Christina G. Rivera, et al.
Published: (2022-01-01)

Patient outcomes following home-based outpatient parenteral antimicrobial therapy and facility-based outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis
by: Shinya Hasegawa, et al.
Published: (2023-01-01)

Outpatient parenteral antimicrobial therapy in Germany: a prospective cohort study protocol
by: Christina Samel, et al.
Published: (2022-11-01)

An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy
by: Abby C. Bradley, et al.
Published: (2023-09-01)

Safety of Nurse- and Self-Administered Paediatric Outpatient Parenteral Antimicrobial Therapy
by: Shanthy Sriskandarajah, et al.
Published: (2020-10-01)

Effectiveness of outpatient parenteral antimicrobial therapy (OPAT) for patients with cranial infection
by: Fatma Kilinc, et al.
Published: (2023-10-01)

Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
by: Fatma Kilinc, et al.
Published: (2023-04-01)

Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study.
by: Doug L Fink, et al.
Published: (2019-01-01)

Stability of antimicrobial agents in an elastomeric infusion pump used for outpatient parenteral antimicrobial therapy
by: Mutsumi Akahane, et al.
Published: (2021-02-01)

Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians.
by: Bernie Carter, et al.
Published: (2021-01-01)

Retrospective cohort analysis of the safety of outpatient parenteral antimicrobial therapy (OPAT) in an academic hospital
by: Kaylyn Billmeyer, et al.
Published: (2022-07-01)

Cost evaluation of a nurse coordinated outpatient parenteral antimicrobial therapy (OPAT) program
by: Huiwen Deng, et al.
Published: (2023-01-01)

Outpatient parenteral antimicrobial therapy (OPAT) in a safety-net hospital: Opportunities for improvement
by: Rory Bouzigard, et al.
Published: (2023-06-01)

Experiences in outpatient parenteral antimicrobial therapy (OPAT): Barriers and challenges from the front lines
by: Nicole Ng, et al.
Published: (2021-01-01)

Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy
by: Jessica J. Tuan, et al.
Published: (2022-01-01)

Outpatient Parenteral Antimicrobial Therapy Practice in United Kingdom: A Single-center Experience
by: Damini Kesharwani, et al.
Published: (2022-11-01)

Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study
by: Colin Sumpter, et al.
Published: (2020-09-01)

Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study
by: Victoria Huang, et al.
Published: (2018-08-01)

A broader view on outpatient parenteral antibiotic therapy (OPAT) stewardship
by: Danielle Hess, et al.
Published: (2022-01-01)

Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy
by: Beatriz Fernández-Rubio, et al.
Published: (2023-02-01)

A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy
by: Abdubadie Kutubi, et al.
Published: (2023-04-01)

Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program
by: Gaurav Agnihotri, et al.
Published: (2023-01-01)

Reflections on implementation of a failure-point–focused outpatient parenteral antimicrobial therapy management program
by: Alice N. Hemenway, et al.
Published: (2022-01-01)

Antibiotic Clinic: Two Years’ Experience in Outpatient Parenteral Antimicrobial Therapy in a Portuguese Hospital
by: Joana Rigor, et al.
Published: (2019-09-01)

Outpatient parenteral antimicrobial therapy for orthopedic infections – a successful public healthcare experience in Brazil
by: Priscila Rosalba Oliveira, et al.
Published: (2016-05-01)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
by: Jacky Tu, et al.
Published: (2023-09-01)

Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study
by: Haneen J. Al Shareef, et al.
Published: (2022-03-01)

Current Practices and Opportunities for Outpatient Parenteral Antimicrobial Therapy in Hospitals: A National Cross-Sectional Survey
by: Hester H. Stoorvogel, et al.
Published: (2022-10-01)

Palliative outpatient parenteral antimicrobial therapy (OPAT): A single center experience and systematic scoping review
by: Oyewole Chris Durojaiye, et al.
Published: (2022-11-01)

Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan
by: Ryota Hase, et al.
Published: (2020-06-01)

Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
by: Al Alawi S, et al.
Published: (2015-08-01)

First Pediatric Outpatient Parenteral Antibiotic Therapy Clinic in Indonesia
by: Aryono Hendarto, et al.
Published: (2020-04-01)

Dalbavancin as an alternative to traditional outpatient parenteral antimicrobial therapy for deep gram-positive infections – an observational, retrospective review
by: Hongkai Bao, et al.
Published: (2024-04-01)

Stability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy
by: Guillaume Loeuille, et al.
Published: (2022-03-01)

Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy
by: Lorena Rodríguez-Martínez, et al.
Published: (2023-08-01)